Lomustine Medak

Lomustine Medak: An effective cytostatic for the treatment of cancer

Lomustine Medak, also known by its international name Lomustine, is a powerful cytotoxic drug used in the treatment of various types of cancer. This drug belongs to the group of nitrosoureas and triazenes and is widely used for lymphogranulomatosis, myeloma, lymphosarcoma, undifferentiated lung cancer, disseminated melanoma of the skin and some brain tumors.

Lomustine is produced by Medak GmbH in Germany, and it has long established itself as one of the important drugs in the treatment of cancer. The drug is available in the form of capsules containing 40 mg of the active substance - Lomustine.

However, before starting treatment with Lomustine, you must familiarize yourself with the special instructions and contraindications. The drug is not recommended for hypersensitivity to its components, as well as for liver and kidney diseases, cachexia, intoxication, leukopenia, thrombocytopenia, pregnancy and lactation. It is important to note that Lomustine may cause side effects such as nausea, vomiting, diarrhea, leukemia and thrombocytopenia. Phlebitis, pigmentation and obliteration of veins, tissue necrosis and contact dermatitis are also possible.

Before using Lomustine, you need to pay attention to its interaction with other drugs. It is compatible with other cytostatic drugs. However, caution should be exercised when used simultaneously with drugs that inhibit hematopoiesis, theophylline or H2-histamine receptor antagonists. The development of cross-resistance between lomustine and other alkylating compounds is also possible. Phenobarbital may reduce the antitumor effect of Lomustine.

In case of an overdose of Lomustine, side effects may increase. In such situations, you must immediately stop taking the drug and seek medical help. Treatment will be symptomatic, since there is no specific antidote.

It is important to note that during treatment with Lomustine it is necessary to carefully monitor the condition of the patient’s hematopoietic system, liver and kidney function. This allows you to evaluate the effectiveness of treatment and timely identify possible complications.

Lomustine Medac is one of the important options in the drug arsenal for the treatment of various types of cancer. However, the decision on its use must be made by the doctor, taking into account the individual characteristics of the patient and the nature of the disease.